Chile has not determined the regulatory status of gene editing in animals. There is little research and no products in development.
Products/Research
- Disease resistance in salmon: Favet-Inbiogen, a biotechnology company, used CRISPR in 2017 to increase the genetic disease resistance in salmon.
Regulatory Timeline
None
NGO Reaction
None
Additional Resources
- Genetic Literacy Project’s FAQ on gene editing
- USDA Biotechnology Annual 2020: Chile
- The regulatory current status of plant breeding technologies in some Latin American and the Caribbean countries